Browse by author
Lookup NU author(s): Professor Roderick Skinner
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation are at an increased risk of developing congestive heart failure. In this population, congestive heart failure is well recognised as a progressive disorder, with a variable period of asymptomatic cardiomyopathy that precedes signs and symptoms. As a result, several clinical practice guidelines have been developed independently to help with detection and treatment of asymptomatic cardiomyopathy. These guidelines differ with regards to definitions of at-risk populations, surveillance modality and frequency, and recommendations for interventions. Differences between these guidelines could hinder the effective implementation of these recommendations. We report on the results of an international collaboration to harmonise existing cardiomyopathy surveillance recommendations using an evidence-based approach that relied on standardised definitions for outcomes of interest and transparent presentation of the quality of the evidence. The resultant recommendations were graded according to the quality of the evidence and the potential benefit gained from early detection and intervention.
Author(s): Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, Nathan PC, Tissing WJE, Shankar S, Sieswerda E, Skinner R, Steinberger J, van Dalen EC, van der Pal H, Wallace WH, Levitt G, Kremer LCM
Publication type: Review
Publication status: Published
Journal: Lancet Oncology
Year: 2015
Volume: 16
Issue: 3
Pages: E123-E136
Print publication date: 01/03/2015
Acceptance date: 01/01/1900
ISSN (print): 1470-2045
ISSN (electronic): 1474-5488
Publisher: ELSEVIER SCIENCE INC
URL: http://dx.doi.org/10.1016/S1470-2045(14)70409-7
DOI: 10.1016/S1470-2045(14)70409-7